Pharmafile Logo
Pharmafocus logo
Advanced Search

Lilly and Boehringer diabetes drug sees US launch

March 24, 2015
Sales and Marketing Boehringer, Glyxambi, Tradjenta, diabetes, empagliflozin/linagliptin, lilly, linagliptin

Lilly and Boehringer Ingelheim’s combo diabetes drug Glyxambi is now available to treat adult patients in the US. Glyxambi (empagliflozin/linagliptin) …

News
FDA image

FDA lifts ban on Pfizer Lilly pain study

March 24, 2015
Research and Development, Sales and Marketing Cancer, FDA, Pfizer, lilly, pain, tanezumab

Pfizer and Eli Lilly will resume Phase III clinical trials of tanezumab following the FDA lifting a ban on trials …

News
Stefan Oschmann

Chief executive promotion at Merck KGaA

March 24, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Karl-Ludwig Kley, Merck, Merck KGaA, Merck Serono, Stefan Oschmann, chief executive

Merck KGaA is to promote its deputy chief executive Stefan Oschmann to replace Karl-Ludwig Kley in the top job next …

News
christa_wirthumer-hoche

EMA elects new vice-chair

March 24, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christa Wirthumer-Hoche, EMA

The European Medicines Agency has elected Dr Christa Wirthumer-Hoche, the head of the Austrian Medicines and Medical Devices Agency, as …

Appointment
Abbvie image

AbbVie invests $30 million to expand in Puerto Rico

March 23, 2015
Manufacturing and Production, Sales and Marketing AbbVie, Alzheimer's, Puerto Rico, barceloneta, c2n

AbbVie is investing $30 million to expand one of its sites in Puerto Rico, and is also backing a promising …

News
Google image

Google files patent for cancer combating wearable

March 23, 2015
Medical Communications, Sales and Marketing Cancer, Nanoparticle Phoresis, google, google x, nano, oncology, wearable, wipo

Google has filed a patent application for a new cancer-fighting wearable device which it says targets the cells in the …

News

Pfizer, Novartis and Celgene among late-stage psoriasis trial advances

March 23, 2015
Sales and Marketing Celgene, Cosentyx, Enbrel, FDA, Novartis, Pfizer, otezla, psoriasis, tofacitinib

Pfizer bosses say they are confident of a positive FDA application for tofacitinib after announcing positive Phase III study results. …

News
Biogen image

Biogen shortens name and posts positive Alzheimer’s results

March 23, 2015
Sales and Marketing AD, Alzheimer's, BIIB037, Biogen, MS, Parkinson's, aducanumab, idec

Biogen Idec is to be known only as Biogen hence forth as the US biotech also reveals positive early results …

News
steve_cottrell3

Maetrics announces new president

March 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing maetrics, steve cottrell

Maetrics has confirmed that Steve Cottrell, previously its vice president of sales, will now assume the role of president at …

Appointment
Janssen image

J&J acquires Index Ventures-owned firm XO1

March 23, 2015
Sales and Marketing Index Ventures, Isis, J&J, JJ, Janssen, vectura, xo1

Johnson & Johnson’s pharma unit Janssen has acquired Index Ventures’ biopharma firm XO1 Limited that develops the promising anti-thrombin antibody …

News
Lilly image

Lilly and Hanmi enter immunological therapy pact

March 20, 2015
Research and Development, Sales and Marketing HM71224, Korea, Sjögren, hanmi, immunological, lilly

Eli Lilly and Korean-based pharma firm Hanmi have entered a collaboration agreement to develop and commercialise an immunological therapy. The …

News
NHS image

Budget 2015: £1.25 billion boost for mental health services

March 20, 2015
Sales and Marketing Budget, Cameron, Miliband, NHS, Osborne, UK

Senior NHS figures have hit out at Chancellor George Osborne’s failure to lay out any specific plans concerning the future …

News
Breo image

GSK and Theravance see FDA nod for asthma indication

March 20, 2015
Sales and Marketing Advair, AstraZeneca, Dulera, FDA, Foradil, GSK, Merck, Symbicort, Theravance, asthma, breo, budesonide/formoterol fumarate dihydratem, ellipta, fluticasone propionate, formoterol fumarate, mometasone/formoterol

An FDA panel has recommended the approval of asthma treatment Breo Ellipta in adults – but voted against supporting its …

News
michael_r_gallagher_actavis

Actavis gains new Allergan directors

March 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Michael Gallagher, Peter McDonnell

Ireland, Dublin-based pharma firm Actavis has added former Allergan members Michael Gallagher and Dr Peter McDonnell to its board of …

Appointment
Sanofi image

Type 1 diabetes market value to double by 2023

March 19, 2015
Research and Development, Sales and Marketing GlobalData, NHS, NICE, Sanofi, diabetes, toujeo, type 1

The treatment market for type 1 diabetes is set to double to around $13.6 billion by 2023 according to analysts …

News
Herceptin image

Breast cancer treatment market booming

March 19, 2015
Research and Development, Sales and Marketing Frost, Herceptin, Kadcyla, Roche, breast cancer, oncology, targeted, tykerb

The increased use of combined targeted therapies for breast cancer is set to lift the market and improve progression-free disease …

News
Daiichi image

AstraZeneca and Daiichi team up for constipation drug

March 19, 2015
Sales and Marketing AstraZeneca, Daiichi, Movantik, constipation, naloxegol, oic

AstraZeneca and Daiichi Sankyo have signed a deal worth around $825 million to jointly commercialise constipation drug Movantik in the …

News
Sanofi image

Sanofi diabetes drug fails to show cardio disease benefit

March 19, 2015
Research and Development, Sales and Marketing ACS, Lixisenatide, Lyxumia, Sanofi, cardio, diabetes

A Phase IIIb study of Sanofi’s diabetes drug lixisenatide has shown it is no better or worse than a placebo …

News
Teva image

Teva and Ignyta shake hands in oncology deal

March 19, 2015
Research and Development, Sales and Marketing CEP-32496, CEP-40125, Levact, RXDX-105, Teva, ignyta, oncology

Ignyta has acquired four oncology R&D assets from Israeli pharma generics giant Teva in a deal worth around $42 million. …

News
paul_wallace

MISSION hires chief business officer from Medivir

March 19, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing medvir, mission, paul wallace

UK, Cambridge-based cancer biotech MISSION Therapeutics has appointed Dr Paul Wallace as its chief business officer. Having worked in business …

Appointment
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026